BARCLAYS PLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 2.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$9,000
-75.0%
12,056
-68.9%
0.00%
Q1 2020$36,000
-75.0%
38,705
-44.8%
0.00%
Q4 2019$144,000
-3.4%
70,120
+34.2%
0.00%
Q3 2019$149,000
-71.0%
52,235
-22.1%
0.00%
Q2 2019$513,000
+2.8%
67,086
+78.6%
0.00%
Q1 2019$499,000
-38.5%
37,560
-27.8%
0.00%
-100.0%
Q4 2018$811,000
-59.7%
51,989
-49.1%
0.00%0.0%
Q3 2018$2,010,000
-8.0%
102,227
+34.2%
0.00%
-50.0%
Q2 2018$2,185,000
+17.3%
76,154
-3.3%
0.00%
+100.0%
Q1 2018$1,863,000
+421.8%
78,736
+373.1%
0.00%
Q4 2017$357,000
+60.1%
16,643
+76.0%
0.00%
Q3 2017$223,000
+87.4%
9,456
+58.3%
0.00%
Q2 2017$119,000
-98.3%
5,974
-98.2%
0.00%
-100.0%
Q1 2017$7,054,000
+8.4%
335,892
-3.0%
0.01%0.0%
Q4 2016$6,509,000
-21.1%
346,155
-12.4%
0.01%
-22.2%
Q3 2016$8,253,000
-47.2%
395,311
-35.5%
0.01%
-57.1%
Q2 2016$15,631,000
+477.6%
612,867
+489.1%
0.02%
+425.0%
Q1 2016$2,706,000
+129.3%
104,035
+270.2%
0.00%
+300.0%
Q4 2015$1,180,000
-83.6%
28,100
-89.9%
0.00%
-88.9%
Q3 2015$7,208,000
+24755.2%
277,250
+31658.3%
0.01%
Q2 2015$29,000
-50.0%
873
-49.2%
0.00%
Q1 2015$58,000
-72.6%
1,720
-67.7%
0.00%
Q4 2014$212,000
-0.5%
5,319
-17.8%
0.00%
Q3 2014$213,000
-44.5%
6,468
-44.6%
0.00%
Q2 2014$384,000
+35.2%
11,665
+51.9%
0.00%
Q1 2014$284,000
-79.6%
7,677
-84.0%
0.00%
-100.0%
Q4 2013$1,390,000
-54.4%
47,945
-46.5%
0.00%
-75.0%
Q3 2013$3,050,000
+1.2%
89,687
-1.9%
0.00%0.0%
Q2 2013$3,015,00091,3790.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,045,400$21,953,00012.28%
SCOPIA CAPITAL MANAGEMENT LP 5,568,306$116,934,0002.16%
GREAT POINT PARTNERS LLC 432,500$9,083,0001.80%
Consonance Capital Management LP 619,419$13,008,0001.36%
RA Capital Management 489,828$10,286,0001.26%
Ghost Tree Capital, LLC 300,000$6,300,0001.17%
DLD Asset Management, LP 281,900$5,920,0000.95%
DLD Asset Management, LP 281,900$5,914,0000.95%
Worth Venture Partners, LLC 36,650$770,0000.68%
Malaga Cove Capital, LLC 51,013$939,0000.57%
View complete list of ACORDA THERAPEUTICS INC shareholders